- XtalPi highlighted its Multi-Agent system as a platform capability that could strengthen differentiation in AI for Science by supporting more autonomous, end-to-end R&D workflows.
- The company said its AI4S 智慧解決方案 business has shifted toward platform-style enablement across sectors such as biopharma and new materials, which could broaden commercialization opportunities beyond single-solution deliveries.
- Revenue rose to RMB 803 million and annual profit climbed to RMB 135 million.
- AI4S 智慧解決方案 revenue increased to RMB 265 million, while 藥物發現解決方案 revenue jumped to RMB 538 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260325-12066840), on March 25, 2026, and is solely responsible for the information contained therein.